<DOC>
	<DOCNO>NCT00383123</DOCNO>
	<brief_summary>The purpose study compare two influenza vaccine ( Fluzone Fluarix ) term immune response elicit safety six month follow-up first vaccination . The Protocol Posting update order comply FDA Amendment Act , Sep 2007 .</brief_summary>
	<brief_title>Study Comparing Immune Response Safety Fluarix Fluzone Influenza Vaccines Children</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>A male female child age 6 month &lt; 18 year time vaccination ; child may may previous administration influenza vaccine previous season acceptable . Subjects parent/guardian investigator believe comply requirement protocol enrol study . Written inform consent obtain subject 's parent/guardian ; assent obtain subject &gt; 10 year . Female subject childbearing potential must agree take pregnancy test . Use investigational nonregistered product ( drug vaccine , study vaccine ) within 30 day precede administration study vaccine , plan use study period . Routine , register childhood vaccination exclusion . History hypersensitivity vaccine . History allergy reaction likely exacerbate component vaccine . Acute disease time enrollment . History Guillain Barr√© syndrome within 6 week receipt prior inactivate influenza virus vaccine . Pregnant lactate female . Receipt influenza vaccine outside study , current ( 200607 ) flu season .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Fluarix</keyword>
	<keyword>Influenza</keyword>
</DOC>